The management of treatment-experienced HIV patients (including virologic failure and switches)

J Cutrell, T Jodlowski, R Bedimo - Therapeutic advances in …, 2020 - journals.sagepub.com
Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led
to very high rates of virologic success for most who remain adherent to therapy. As a result …

The management of treatment-experienced HIV patients (including virologic failure and switches)

J Cutrell, T Jodlowski, R Bedimo - Therapeutic …, 2020 - utsouthwestern.elsevierpure.com
Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led
to very high rates of virologic success for most who remain adherent to therapy. As a result …

The management of treatment-experienced HIV patients (including virologic failure and switches).

J Cutrell, T Jodlowski, R Bedimo - Therapeutic Advances in …, 2020 - europepmc.org
Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led
to very high rates of virologic success for most who remain adherent to therapy. As a result …

The management of treatment-experienced HIV patients (including virologic failure and switches)

J Cutrell, T Jodlowski, R Bedimo - … advances in infectious …, 2020 - pubmed.ncbi.nlm.nih.gov
Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led
to very high rates of virologic success for most who remain adherent to therapy. As a result …

[HTML][HTML] The management of treatment-experienced HIV patients (including virologic failure and switches)

J Cutrell, T Jodlowski, R Bedimo - Therapeutic Advances in …, 2020 - ncbi.nlm.nih.gov
Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led
to very high rates of virologic success for most who remain adherent to therapy. As a result …